242 related articles for article (PubMed ID: 25573091)
1. Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia.
Castelli J; Simon A; Louvel G; Henry O; Chajon E; Nassef M; Haigron P; Cazoulat G; Ospina JD; Jegoux F; Benezery K; de Crevoisier R
Radiat Oncol; 2015 Jan; 10():6. PubMed ID: 25573091
[TBL] [Abstract][Full Text] [Related]
2. A Nomogram to predict parotid gland overdose in head and neck IMRT.
Castelli J; Simon A; Rigaud B; Lafond C; Chajon E; Ospina JD; Haigron P; Laguerre B; Loubière AR; Benezery K; de Crevoisier R
Radiat Oncol; 2016 Jun; 11():79. PubMed ID: 27278960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effectiveness of novel single-intervention adaptive radiotherapy strategies based on daily dose accumulation.
Ciarmatori A; Maffei N; Mistretta GM; Ceroni P; Bernabei A; Meduri B; D'Angelo E; Bruni A; Giacobazzi P; Lohr F; Guidi G
Med Dosim; 2019 Winter; 44(4):379-384. PubMed ID: 30871864
[TBL] [Abstract][Full Text] [Related]
4. Optimal adaptive IMRT strategy to spare the parotid glands in oropharyngeal cancer.
Zhang P; Simon A; Rigaud B; Castelli J; Ospina Arango JD; Nassef M; Henry O; Zhu J; Haigron P; Li B; Shu H; De Crevoisier R
Radiother Oncol; 2016 Jul; 120(1):41-7. PubMed ID: 27372223
[TBL] [Abstract][Full Text] [Related]
5. A density assignment method for dose monitoring in head-and-neck radiotherapy.
Barateau A; Perichon N; Castelli J; Schick U; Henry O; Chajon E; Simon A; Lafond C; De Crevoisier R
Strahlenther Onkol; 2019 Feb; 195(2):175-185. PubMed ID: 30302507
[TBL] [Abstract][Full Text] [Related]
6. Volumetric changes of the parotid gland during IMRT based on mid-treatment imaging: implications for parotid stem cell sparing strategies in head and neck cancer.
Gjini M; Ahmed S; Kalnicki S; Tomé WA; Garg MK; Kabarriti R; Brodin NP
Acta Oncol; 2022 Sep; 61(9):1069-1074. PubMed ID: 35978529
[TBL] [Abstract][Full Text] [Related]
7. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
[TBL] [Abstract][Full Text] [Related]
8. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas.
Bandlamudi BP; Sharan K; Yathiraj PH; Singh A; Reddy A; Fernandes DJ; Srinivasa VM
J Cancer Res Ther; 2018; 14(6):1220-1224. PubMed ID: 30488833
[TBL] [Abstract][Full Text] [Related]
9. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
11. Cone-beam computed tomography (CBCT) for adaptive image guided head and neck radiation therapy.
Hvid CA; Elstrøm UV; Jensen K; Grau C
Acta Oncol; 2018 Apr; 57(4):552-556. PubMed ID: 29125035
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
14. Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer.
Maheshwari G; Dhanawat A; Kumar HS; Sharma N; Jakhar SL
J Cancer Res Ther; 2020; 16(3):600-604. PubMed ID: 32719274
[TBL] [Abstract][Full Text] [Related]
15. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
[TBL] [Abstract][Full Text] [Related]
16. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
17. Adaptive replanning strategies accounting for shrinkage in head and neck IMRT.
Wu Q; Chi Y; Chen PY; Krauss DJ; Yan D; Martinez A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):924-32. PubMed ID: 19801104
[TBL] [Abstract][Full Text] [Related]
18. Adaptive radiotherapy for head and neck cancer.
Castelli J; Simon A; Lafond C; Perichon N; Rigaud B; Chajon E; De Bari B; Ozsahin M; Bourhis J; de Crevoisier R
Acta Oncol; 2018 Oct; 57(10):1284-1292. PubMed ID: 30289291
[TBL] [Abstract][Full Text] [Related]
19. Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.
Miah AB; Gulliford SL; Morden J; Newbold KL; Bhide SA; Zaidi SH; Hall E; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e69-e76. PubMed ID: 26994893
[TBL] [Abstract][Full Text] [Related]
20. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
